-
Symbol
-
IONS on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock
-
Latest Disclosed Ownership
-
15.9M shares
-
Security Ownership
-
10%
Shares, Excluding Options vs Price
Value, Excluding Options
T. Rowe Price Investment Management, Inc. ownership in IONIS PHARMACEUTICALS INC Common Stock (IONS)
2025-02-07 - T. Rowe Price Investment Management, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.9M shares of IONIS PHARMACEUTICALS INC Common Stock (IONS).
This represents 10% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.